Molecular Imaging of Plaque Vulnerability

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions

Plaque, Atherosclerotic

Interventions

DRUG

18F-choline PET-MR imaging

Dynamic and static 18F-choline PET-MR imaging

Trial Locations (1)

RECRUITING

Maastricht University Medical Center, Maastricht

All Listed Sponsors

lead

Maastricht University Medical Center

OTHER

NCT02640313 - Molecular Imaging of Plaque Vulnerability | Biotech Hunter | Biotech Hunter